Psychopharmacology 2005: Vol 179 Table of Contents

2005·2 MB·English

Psychopharmacology
This journal was founded as Editors), J.O. Cole, J. Gerlach, M. Hamilton, J. Robbins, D.R. Sibley, D.M. Warburton, H. de Wit.
Psychopharmacologia in 1959 and was renamed Leysen, F. Sulser. As of Vol. 85 (1985): H. Barry As of Vol. 142 (1999): P.J. Cowen, J. Gerlach, M.A.
Psychopharmacology beginning with Ill, D.E. Casey, J.O. Cole, J. Gerlach, $.D. Glick, Geyer, A.R. Green, J.H. Krystal, J. Leysen, K.A.
Vol. 46 (1976). A.R. Green, M. Hamilton, J. Leysen, T.W. Robbins, Miczek, T.W. Robbins, D.R. Sibley, D.M.
The journal has been edited by the following F. Sulser. As of Vol. 92 (1987): H. Barry III, D.E. Warburton, H. de Wit. As of Vol. 151 (2000): PJ.
Managing Editors: Casey, J.Gerlach, S.D. Glick, A.R. Green, J. Cowen, J. Gerlach, M.A. Geyer, A.R. Green, J.H.
Leysen, T.W. Robbins, B.J. Spring, F. Sulser, D.M. Krystal, K.A. Miczek, T.W. Robbins, D.R. Sibley,
Vol. 1 (1959), E. Rothlin and A. Wikler; Vol. 2 Warburton. As of Vol. 98 (1989): H. Barry III, D.E. D.M. Warburton, H. de Wit. As of Vol. 152 (2000):
(1961), E. Rothlin and H. Isbell; Vol. 3 (1962), Casey, J. Gerlach, S.D. Glick, A.R. Green, J. P.J. Cowen, J. Gerlach, M.A. Geyer, A.R. Green, D.
E. Rothlin and A. Wikler; Vol. 4 (1963)—Vol. 7 Leysen, T.W. Robbins, D.R. Sibley, B.J. Spring, Hoyer, J.H. Krystal, K.A. Miczek, T.W. Robbins,
(1965), J.O. Cole and E. Rothlin; Vol. 8 D.M. Warburton. As of Vol. 106 (1992): D.E. D.R. Sibley, D.M. Warburton, H. de Wit. As of Vol.
(1965)—Vol. 16 (1969), J.O. Cole, E. Jacobsen, Casey, J. Gerlach, M.A. Geyer, A.R. Green, J. 167/2 (2003): P.J. Cowen, M.A. Geyer, A.R. Green,
M.E. Jarvik, M. Shepherd; Vol. 17 (1970), J.O. Leysen, K.A. Miczek, T.W. Robbins, D.R. Sibley, D. Hoyer, J.H. Krystal, K.A. Miczek, T.W.
Cole, E. Jacobsen, C. Kornetzky, M. Shepherd; BJ. Spring, D.M. Warburton. As of Vol. 109 Robbins, D.R. Sibley, D.M. Warburton, H. de Wit.
Vol. 18 (1970)-Vol. 27 (1972), J.O. Cole, M.
(1992): D.E. Casey, J. Gerlach, M.A. Geyer, A.R. As of Vol. 171/1 (2003): P.J. Cowen, V.H. Curran,
Hamilton, E. Jacobsen, C. Kornetzky; Vol. 28 Green, J. Leysen, K.A. Miczek, T.W. Robbins, M.A. Geyer, A.R. Green, D. Hoyer, J.H. Krystal,
(1973)-Vol. 35 (1974), J.O. Cole, M. Hamilton, E. D.R. Sibley, B.J. Spring, D.M. Warburton, H. de U.A. Miczek, T.W. Robbins, D.R. Sibley, D.M.
Jacobsen, C. Kornetzky, R.W. Russell; Vol. 36 Wit. Warburton, H. de Wit.
(1974)—-Vol. 69 (1980), H. Barry III, J.O. Cole, M. As of Vol. 117 (1995): D.E. Casey, J. As of Vol. 172/1 (2004): PJ. Cowen, H.V. Curran,
Hamilton, E. Jacobsen, R.W. Russell; Vol. 70 Gerlach, M.A. Geyer, A.R. Green, J. Leysen, M.A. Geyer, A.R. Green, D. Hoyer, J.H. Krystal,
(1980)—-Vol. 77 (1982), H. Barry III, J.O. Cole, M. K.A. Miczek, T.W. Robbins, D.R. Sibley, D.M. K.A. Miczek, T.W. Robbins, D.R. Sibley, H. de Wit.
Hamilton, T.W. Robbins, R.W. Russell. Warburton, H. de Wit. As of Vol. 129 (1997): D.E.
Starting with Vol. 80 (1983) the Editors have Casey, P.J. Cowen, J. Gerlach, M.A. Geyer, A.R.
been: H. Barry III, T.W. Robbins (Coordinating Green, J. Leysen, K.A. Miczek, W. Potter, T.W.
Contents of Volume 179 - 2005
Abate G— Neri S Batman AM, Munzar P, Beardsley PM: Black MD: Therapeutic potential of
Abi-Dargham A— Cho H-S Attenuation of nicotine’s discriminative positive AMPA modulators and their
Abi-Saab W — Cho H-S stimulus effects in rats and its locomotor relationship to AMPA receptor subunits.
Abi-Saab W > Krystal JH activity effects in mice by serotonergic A review of preclinical data 154
Aerts N > Steckler T 5-HT>,a/2c receptor agonists 393 Bland ST— Der-Avakian A
Alder JT Lai MK Baunez C— Turle-Lorenzo N Body S—> Zhang Z
Ali O— Elsabagh S Beardsley PM— Batman AM Bongiovanni R— Jaskiw GE
Amalric M— Turle-Lorenzo N Bechara A— Rizzo M Bonini JS—> Kerr DS :
Andersen GJ— Rizzo M Belger A— Cho H-S Bourin M— Nick Dhonnchadha BA
de Andrade TGC—S do s Santos L Belger A— Krystal JH Boutrel B— Kenny PJ
Antoniou K— Solinas M Bennet A— Cho H-S Bradshaw CM— Zhang Z
Anum EA Varvel SA Benneyworth MA, Smith RL, Barrett RJ, Brammer M-—> Rubia K
Arlt J— Kellner M Sanders-Bush E: Complex Breier A— Krystal JH
Asgari K—> Zhang Z discriminative stimulus properties of (+) Breysse N— Turle-Lorenzo N
Asnis GM-— De La Garza II R lysergic acid diethylamide (LSD) in Bringlov E— Persson J
CS7BI/6J mice 854 Britton TC— Johnson MP
Baez M— Linden A-M Bert B, Felicio LF, Fink H, Nasello AG: Brown G—> Mead AN
Bailey JE— Wilson SJ The use of sudden darkness in mice: a Brown PR— Weerts EM
Ballard T— Spinelli S behavioural and pharmacological Brown S—> Chambers RA
Ballard TM— Higgins GA approach 846 Bruno CM-—> Neri S
Ballard TM, Woolley ML, Prinssen E, Bertorelli R—> Varty GB Buccafusco JJ— Terry Jr AV
Huwyler J, Porter R, Spooren W: The Bespalov AY — Zakharova ES Butelman ER— Zhang Y
effect of the mGluS receptor antagonist Betz A, Ishiwari K, Wisniecki A, Huyn N,
MPEP in rodent tests of anxiety and Salamone JD: Quetiapine (Seroquel) Caldwell DP— Rezvani AH
cognition: a comparison 218 shows a pattern of behavioral effects Calvagno S— Neri S
Balsara JJ, Jadhav SA, Gaonkar RK, similar to the atypical antipsychotics Cammarota M— Kerr DS
Gaikwad RV, Jadhav JH: Effects of the clozapine and olanzapine: studies with Carli M— Greco B
antidepressant trazodone, a 5-HT2,/2c tremulous jaw movements in rats 383 Carrasco GA—Grippo AJ
receptor antagonist, on dopamine- Bevilaqua LRM-— Kerr DS Carroll ME— Morgan AD
dependent behaviors in rats 597 Biondo A-M, Clements RLH, Hayes DJ, Case JM— Fuchs RA
Bannerman DM > Denk F Eshpeter B, Greenshaw AJ: NMDA or Chambers RA, Jones RM, Brown S,
Barda D— Johnson MP AMPA/kainate receptor blockade Taylor JR: Natural reward-related
Barkai G— Dolberg OT prevents acquisition of conditioned place learning in rats with neonatal ventral
Barrett RJ Benneyworth MA preference induced by D2,; dopamine hippocampal lesions and prior cocaine
Bartoszyk GD-— Terry Jr AV receptor stimulation in rats 189 exposure 470
IV
Chen CP— Lai MK S: Differential effects of topiramate in Gibson KM— Weerts EM
Chen Z—Grippo AJ patients with traumatic brain injury and Goff DC, Herz L, Posever T, Shih V, Tsai
Cheskin LJ, Hess JM, Henningfield J, obesity—a case series 838 G, Henderson DC, Freudenreich O,
Gorelick DA: Calorie restriction Dunn JM, Inderwies BR, Licata SC, Pierce Evins AE, Yovel I, Zhang H, Schoenfeld
increases cigarette use in adult RC: Repeated administration of AMPA D: A six-month, placebo-controlled trial
smokers 430 or a metabotropic glutamate receptor of p-cycloserine co-administered with
Cho H-S, D’Souza DC, Gueorguieva R, agonist into the rat ventral tegmental conventional antipsychotics in
Perry EB, Madonick S, Karper LP, area augments the subsequent behavioral schizophrenia patients 144
Abi-Dargham A, Belger A, Abi-Saab W, hyperactivity induced by cocaine 172 Goldberg SR— Solinas M
Lipschitz D, Bennet A, Seibyl JP, Durkalski V— Jaskiw GE Goldberg SR— Solinas M
Krystal JH: Absence of behavioral Goldberg SR, Panlilio LV, Harvey DM,
sensitization in healthy human subjects Eerdekens M— Gagiano C Yasar S, Heishman SJ, Henningfield JE:
following repeated exposure to Egerton A, Reid L, McKerchar CE, Morris Nicotine may reinforce intravenous
ketamine 136 BJ, Pratt JA: Impairment in perceptual drug-taking behavior in drug users: reply
Chung C, Remington G: Predictors and attentional set-shifting following PCP to R. Dar and H. Frenk (2005) 518
markers of clozapine response 317 administration: a rodent model of set- Goodwin AK—> Weerts EM
Cilio D> Neri S ; shifting deficits in schizophrenia 77 Goodwin GM-> Scarna A
Clénet F— Nick Dhonnchadha BA Elliott JM— Saadat KS Gorelick DA— Cheskin LJ
Clarke D— Pace-Schott EF Elsabagh S, Hartley DE, Ali O, Williamson Greco B, Invernizzi RW, Carli M:
Cleare AJ— Rubia K EM, File SE: Differential cognitive Phencyclidine-induced impairment in
Clements RLH — Biondo A-M effects of Ginkgo biloba after acute and attention and response control depends
Clifton PG— Thornton-Jones ZD chronic treatment in healthy young on the background genotype of mice:
Coimbra NC — Rebougas ECC volunteers 437 reversal by the mGLU;,; receptor
Colado MI-— Saadat KS Emkey R-— Johnson MP agonist LY379268 68
Cools AR-> de Jong TR Enderlin M— Higgins GA Green AR — Saadat KS
Costantini VJA— Ferretti V Engel JA— Klamer D Greenshaw AJ— Biondo A-M
Covington Ill HE— Yap JJ Eshpeter B—> Biondo A-M Griffiths RR Weerts EM
Cowen PJ— Scarna A Esiri MM— Lai MK Grilli M—> Varty GB
Crane JW-—Grippo AJ Evans KA—> Fuchs RA Grippo AJ, Sullivan NR, Damjanoska KJ,
Crissman AM-— Zhang H-T Evins AE Goff DC Crane JW, Carrasco GA, Shi J, Chen Z,
Croft RJ— Silber BY Garcia F, Muma NA, Van de Kar LD:
Cryan JF— Jacobson LH Fabrizio KR— De La Garza II R Chronic mild stress induces behavioral
Cryan JF— Page ME Fejgin K— Klamer D and physiological changes, and may
Feldon J— Spinelli S alter serotonin 1A receptor function, in
D’Souza DC— Cho H-S Feldon J— Yee BK male and cycling female rats 769
D’Souza DC-— Krystal JH Felicio LF— Bert B Grobin AC, VanDoren MJ, Porrino LJ,
Dalley JW— Murphy ER Ferré S— Solinas M Morrow AL: Cortical 3a-hydroxy-5a-
Damjanoska KJ— Grippo AJ Ferretti V, Florian C, Costantini VJA, pregnan-20-one levels after acute
Danysz W — Zakharova ES Roullet P, Rinaldi A, De Leonibus E, administration of A9-
Dar R, Frenk H: Nicotine may reinforce Oliverio A, Mele A: Co-activation of tetrahydrocannabinol, cocaine and
intravenous drug-taking behavior in drug glutamate and dopamine receptors morphine 544
users: a comment on Harvey et al. within the nucleus accumbens is Gross Y — Dolberg OT
(2004) 516 required for spatial memory Grzelak ME-— Varty GB
Datta R—> Yap JJ consolidation in mice 108 Gueorguieva R— Cho H-S
De La Garza II R, Asnis GM, Fabrizio KR, File SE— Elsabagh S Gueorguieva R— Krystal JH
Pedrosa E: Acute diclofenac treatment Fink H— Bert B Guthrie DH— Varty GB
attenuates lipopolysaccharide-induced Fleischer R— Rocha BA Gyertyan I Laszy J
alterations to basic reward behavior and Florian C > Ferretti V
HPA axis activation in rats 356 Forlani A— Varty GB Haman M-— Higgins GA
De Leonibus E—F erretti V Francis PT > Lai MK Harding S— Lé AD
Deak T— Der-Avakian A Fredduzzi S— Varty GB Hart CL— Pace-Schott EF
Debonnel G— Hasegawa S Freitas RL— Reboucgas ECC Hartley DE— Elsabagh S
Deng C-— Zhang H-T Frenk H— Dar R Harvey DM— Goldberg SR ’
Denk F, Walton ME, Jennings KA, Sharp T, Freudenreich O— Goff DC Hascoét M— Nick Dhonnchadha BA
Rushworth MFS, Bannerman DM: Froest! W— Weerts EM Hasegawa S, Watanabe A, Nguyen KQ,
Differential involvement of serotonin Fu CHY => Rubia K Debonnel G, Diksic M: Chronic
and dopamine systems in cost-benefit Fuchs RA, Evans KA, Mehta RH, Case JM, administration of citalopram in olfactory
decisions about delay or effort 587 See RE: Influence of sex and estrous bulbectomy rats restores brain 5-HT
Der-Avakian A, Will MJ, Bland ST, Deak cyclicity on conditioned cue-induced synthesis rates: an autoradiographic
T, Nguyen KT, Schmid MJ, Spencer RL, reinstatement of cocaine-seeking study 781
Watkins LR, Maier SF: Surgical and behavior in rats 662 Haskell CF, Kennedy DO, Wesnes KA,
pharmacological suppression of Funk D-Lé AD Scholey AB: Cognitive and mood
glucocorticoids prevents the improvements of caffeine in habitual
enhancement of morphine conditioned Gagiano C, Read S, Thorpe L, Eerdekens consumers and habitual non-consumers
place preference by uncontrollable stress M, van Hove I: Short- and long-term of caffeine 813
in rats 409 efficacy and safety of risperidone in Hayes DJ— Biondo A-M
Dess NK— Morgan AD adults with disruptive behavior Hayward RC— Rogers PJ
De Vivo M— Zhang H-T disorders 629 Heatherley SV — Rogers PJ
Diederich K, Koch M: Role of the Gaikwad RV— Balsara JJ Hegerl U— Mergl R
pedunculopontine tegmental nucleus in Gale MC— Yap JJ Heishman SJ— Goldberg SR
sensorimotor gating and reward-related Gaonkar RK > Balsara JJ Henderson DC Goff DC
behavior in rats 402 Garcia F—Grippo AJ Henningfield J— Cheskin LJ
Diksic M— Hasegawa S Gasparini F— Kenny PJ Henningfield JE— Goldberg SR
Djahansouzi S— Walpurger V Gasparini F— Page ME Herrick-Davis K— Purohit A
Dolberg OT, Barkai G, Gross Y, Schreiber Gatti-McArthur S— Spinelli S Herz L— Goff DC
Hess JM— Cheskin LJ de Jong TR, Pattij T, Veening JG, Labrie V— Lipina T
Hickey GJ— Rocha BA Waldinger MD, Cools AR, Olivier B: Lai MK, Tsang SW, Alder JT, Keene J,
Higgins GA— Varty GB Effects of chronic selective serotonin Hope T, Esiri MM, Francis PT, Chen
Higgins GA, Ballard TM, Enderlin M, reuptake inhibitors on 8-OH-DPAT- CP: Loss of serotonin 5-HT>, receptors
Haman M, Kemp JA: Evidence for induced facilitation of ejaculation in in the postmortem temporal cortex
improved performance in cognitive tasks rats: comparison of fluvoxamine and correlates with rate of cognitive decline
following selective NR2B NMDA paroxetine 509 in Alzheimer’s disease 673
receptor antagonist pre-treatment in the Juckel G—> Mergl R Lamers CTJ— Rizzo M
rat 85 Justinova Z— Solinas M Large CH— Idris NF
Higgins GA, Miczek KA: Glutamate Juzytsch W—>Lé AD Laszlovszky I— Laszy J
receptor subtypes: promising new Laszy J, Laszlovszky I, Gyertyan I:
pharmacotherapeutic targets | Kane M-— Rogers PJ Dopamine D, receptor antagonists
Hill J— Rogers PJ Kapps M-> Spinelli S improve the learning performance in
Himmerich H, Koethe D, Schuld A, Karper LP— Cho H-S memory-impaired rats 567
Yassouridis A, Pollmacher T: Plasma Keene J— Lai MK Lavreysen H— Steckler T
levels of leptin and endogenous immune Kellner M, Muhtz C, Stark K, Yassouridis Le Merrer J-> Mead AN
modulators during treatment with A, Arlt J, Wiedemann K: Effects of a Lee F— Rubia K
carbamazepine or lithium 447 metabotropic glutamate,; receptor Lee TMC— Yip JTH
Ho A— Zhang Y agonist (LY544344/LY354740) on panic Lesage ASJ— Steckler T
Hobson JA— Pace-Schott EF anxiety induced by cholecystokinin Levin ED— Rezvani AH
Hockemeyer J— Solinas M tetrapeptide in healthy humans: Levine L— Krystal JH
Hodge CW — Schroeder JP preliminary results 310 Licata SC— Dunn JM
Hodgson RA— Varty GB Kemp JA— Higgins GA Lichtman AH> Varvel SA
Hope T— Lai MK Kemp JA— Kew JNC Linden A-M, Shannon H, Baez M, Yu JL,
Hopper AT— Zhang H-T Kennedy D> Scholey A Koester A, Schoepp DD: Anxiolytic-like
Hornback WJ— Johnson MP Kennedy DO-— Haskell CF activity of the mGLU2/3 receptor
Hove IV — Gagiano C Kenny PJ, Boutrel B, Gasparini F, Koob agonist LY354740 in the elevated plus
Huang Y— Zhang H-T GF, Markou A: Metabotropic glutamate maze test is disrupted in metabotropic
Hunsberger T—> Krystal JH 5 receptor blockade may attenuate glutamate receptor 2 and 3 knock-out
Hunter JC— Varty GB cocaine self-administration by mice 284
Huwy!er J— Ballard TM decreasing brain reward function in Lipina T, Labrie V, Weiner I, Roder J:
Huyn N— Betz A rats 247 Modulators of the glycine site on
Kerr DS, Bevilaqua LRM, Bonini JS, NMDA receptors, D-serine and ALX
Idris NF, Repeto P, Neill JC, Large CH: Rossato JI, Kohler CA, Medina JH, 5407, display similar beneficial effects
Investigation of the effects of Izquierdo I, Cammarota M: Angiotensin to clozapine in mouse models of
lamotrigine and clozapine in improving II blocks memory consolidation through schizophrenia 54
reversal-learning impairments induced an AT> receptor-dependent Lipschitz D— Cho H-S
by acute phencyclidine and mechanism 529 Liu N— Krystal JH
b-amphetamine in the rat 336 Kew JNC, Kemp JA: lonotropic and Liu Y, Roberts DCS, Morgan D: Effects of
Ignaccolo L— Neri S metabotropic glutamate receptor extended-access self-administration and
Inderwies BR— Dunn JM structure and pharmacology 4 deprivation on breakpoints maintained
Interlandi D— Neri S Kirkbride B— Jaskiw GE by cocaine in rats 644
Invernizzi RW — Greco B Kishi R— Rebougas ECC Lu SX— Varty GB
Ishiwari K— Betz A Klamer D, Palsson E, Fejgin K, Zhang J,
Italiano C— Neri S Engel JA, Svensson L: Activation of a Miiller CE— Solinas M
Izquierdo I— Kerr DS nitric-oxide-sensitive CAMP pathway Madonick S—> Cho H-S
with phencyclidine: elevated Maier SF— Der-Avakian A
Jacobson LH, Cryan JF: Differential hippocampal cAMP levels are Malaguarnera M— Neri S
sensitivity to the motor and hypothermic temporally associated with deficits in Markou A— Kenny PJ
effects of the GABAg receptor agonist prepulse inhibition 479 Markou A-— Paterson NE
baclofen in various mouse strains 688 Koch M-— Diederich K Matsumoto M, Tachibana K, Togashi H,
Jadhav JH— Balsara JJ Koester A— Linden A-M Tahara K, Kojima T, Yamaguchi T,
Jadhav SA— Balsara JJ Koethe D—> Himmerich H Yoshioka M: Chronic treatment with
Jagdmann GE— Johnson MP Kéhler CA— Kerr DS milnacipran reverses the impairment of
Jakobs C— Weerts EM Kojima T— Matsumoto M synaptic plasticity induced by
Jaskiw GE, Kirkbride B, Newbould E, Koob GF— Kenny PJ conditioned fear stress 606
Young D, Durkalski V, Bongiovanni R: Kreek MJ— Zhang Y Mauceri B—> Neri S
Clozapine-induced dopamine release in Krystal JH— Cho H-S Mavrogiorgou P— Mergi R
the medial prefrontal cortex is Krystal JH, Abi-Saab W, Perry E, D’Souza McDougall L— Krystal JH
augmented by a moderate concentration DC, Liu N, Gueorguieva R, McDougall McGuire P— Rubia K
of locally administered tyrosine but L, Hunsberger T, Belger A, Levine L, McKerchar CE— Egerton A
attenuated by high tyrosine Breier A: Preliminary evidence of McKinzie DL— Johnson MP
concentrations or by tyrosine attenuation of the disruptive effects of McTavish SFB—> Scarna A
depletion 713 the NMDA glutamate receptor Mead AN, Brown G, Le Merrer J,
Jennings KA— Denk F antagonist, ketamine, on working Stephens DN: Effects of deletion of
Johnson MP, Barda D, Britton TC, Emkey memory by pretreatment with the group grial or gria2 genes encoding
R, Hornback WJ, Jagdmann GE, II metabotropic glutamate receptor glutamatergic AMPA-receptor subunits
McKinzie DL, Nisenbaum ES, Tizzano agonist, LY354740, in healthy human on place preference conditioning in
JP, Schoepp DD: Metabotropic subjects 303 mice 164
glutamate 2 receptor potentiators: Medina JH— Kerr DS
receptor modulation, frequency- Lé AD, Harding S, Juzytsch W, Funk D, Megens A- > Steckler T
dependent synaptic activity, and efficacy Shaham Y: Role of alpha-2 Mehta RH—> Fuchs RA
in preclinical anxiety and psychosis adrenoceptors in stress-induced Mele A— Ferretti V
model(s) 271 reinstatement of alcohol seeking and Merg!l R, Mavrogiorgou P, Juckel G,
Jones RM— Chambers RA alcohol self-administration in rats 366 Zaudig M, Hegerl U: Can a subgroup of
VI
OCD patients with motor abnormalities Wigren PE, Ward AS, Hart CL, Clarke GJ: Impaired perception of self-motion
and poor therapeutic response be D, Morgan A, Hobson JA: Sleep quality (heading) in abstinent ecstasy and
identified? 826 deteriorates over a binge-abstinence marijuana users 559
Miczek KA— Higgins GA cycle in chronic smoked cocaine Robbins TW — Murphy ER
Miczek KA— Yap JJ users 873 Rocha BA, Fleischer R, Schaeffer JM,
Millan MJ: N-Methyl-p-aspartate receptors Page ME, Szeliga P, Gasparini F, Cryan JF: Rohrer SP, Hickey GJ: 17{3-Estradiol-
as a target for improved antipsychotic Blockade of the mGlu5 receptor induced antidepressant-like effect in the
agents: novel insights and clinical decreases basal and stress-induced Forced Swim Test is absent in estrogen
perspectives 30 cortical norepinephrine in rodents 240 receptor-{3 knockout (BERKO)
Morato S— Reboucas ECC Panagis G— Vlachou S mice 637
Morgan A— Pace-Schott EF Panlilio LVG oldberg SR Roder J— Lipina T
Morgan AD, Dess NK, Carroll ME: Panlilio LV, Thorndike EB, Schindler CW: Rogers PJ, Heatherley SV, Hayward RC,
Escalation of intravenous cocaine Lorazepam reinstates punishment- Seers HE, Hill J, Kane M: Effects of
self-administration, progressive-ratio suppressed remifentanil self- caffeine and caffeine withdrawal on
performance, and reinstatement in rats administration in rats 374 mood and cognitive performance
selectively bred for high (HiS) and low Papafotiou K— Silber BY degraded by sleep restriction 742
(LoS) saccharin intake 520 Pappas LA-— Solinas M Rogers RD— Scarna A
Morgan D-— Liu Y Parker EM— Varty GB Rohrer SP— Rocha BA
Morris BJ— Egerton A Paterson NE, Markou A: The metabotropic Rose GM— Zhang H-T
Morrow AL—>Grobin AC glutamate receptor 5 antagonist MPEP Rossato JI— Kerr DS
Muhtz C-— Kellner M decreased break points for nicotine, Roullet P— Ferretti V
Muma NA-—Grippo AJ cocaine and food in rats 255 Rubia K, Lee F, Cleare AJ, Tunstall N,
Munzar P— Batman AM Pattij T— de Jong TR Fu CHY, Brammer M, McGuire P:
Murphy ER, Dalley JW, Robbins TW: Pedrosa E— De La Garza II R Tryptophan depletion reduces right
Local glutamate receptor antagonism in Perry E> Krystal JH inferior prefrontal activation during
the rat prefrontal cortex disrupts Perry EB— Cho H-S response inhibition in fast, event-related
response inhibition in a visuospatial Persson J, Bringlov E, Nilsson L-G, fMRI 791
attentional task 99 Nyberg L: Herbal extracts and memory Rushworth MF—S De nk F
Muzur A-— Pace-Schott EF enhancement: response to Scholey
etal. 708 Roberts DCS— Liu Y
Nasello AG— Bert B Pierce RC— Dunn JM Saadat KS, O’Shea E, Colado MI, Elliott
Neill JC— Idris NF Pietrowsky R— Walpurger V JM, Green AR: The role of 5-HT in the
Neri S, Bruno CM, Pulvirenti D, Pollmacher T— Himmerich H impairment of thermoregulation
Malaguarnera M, Italiano C, Mauceri B, Pond AJ— Varty GB observed in rats administered MDMA
Abate G, Cilio D, Calvagno S, Tsami A, Porrino LJ-—> Grobin AC (‘ecstasy’) when housed at high ambient
Ignaccolo L, Interlandi D, Prestianni L, Porter R— Ballard TM temperature 884
Ricchena M, Noto R: Randomized Posever T— Goff DC Salamone JD-— Betz A
clinical trial to compare the effects of Pratt JA— Egerton A Sanders-Bush E— Benneyworth MA
methadone and buprenorphine on the Prestianni L— Neri S Sanger G— O'Neill MF
immune system in drug abusers 700 Prickaerts J— Steckler T dos Santos L, de Andrade TGCS, Zangrossi
Newbould E- Jaskiw GE Prinssen E— Ballard TM Jr H: Serotonergic neurons in the median
Nguyen KQ-—> Hasegawa S Pryce CR— Spinelli S raphe nucleus regulate inhibitory
Nguyen KT— Der-Avakian A Pulvirenti D— Neri S avoidance but not escape behavior in the
Nick Dhonnchadha BA, Ripoll N, Clénet F, Purohit A, Smith C, Herrick-Davis K, rat elevated T-maze test of anxiety 733
Hascoét M, Bourin M: Implication of Teitler M: Stable expression of Sauer CG— Rizzo M
5-HT> receptor subtypes in the constitutively activated mutant hSHT, Savoldi M— Rebougas ECC
mechanism of action of antidepressants and hSHT> serotonin receptors: inverse Scarna A, McTavish SFB, Cowen PJ,
in the four plates test 418 agonist activity of antipsychotic Goodwin GM, Rogers RD: The effects
Nicolussi E— Varty GB drugs 461 of a branched chain amino acid mixture
Nilsson L-G— Persson J supplemented with tryptophan on
Nisenbaum ES — Johnson MP Quarta D— Solinas M biochemical indices of neurotransmitter
Nomikos GG— Vlachou S function and decision-making 761
Noto R- Neri S Ramaekers JG— Rizzo M Schaeffer JM— Rocha BA
Nutt DJ—> Wilson SJ Read S— Gagiano C Schindler CW — Panlilio LV
Nyberg L— Persson J Rebougas ECC, Segato EN, Kishi R, Freitas Schlussman SD— Zhang Y
RL, Savoldi M, Morato S, Coimbra NC: Schmid MJ-— Der-Avakian A
O'Donnell JM— Zhang H-T Effect of the blockade of |: ;-opioid and Schmitt HP: Pouring oil into the fire? On
O'Neill MF, Sanger G, Ornstein PL, S5HT>,-serotonergic/« ;-noradrenergic the conundrum of the beneficial effects
Osborne DJ, Woodhouse SM: receptors on sweet-substance-induced of NMDA receptor antagonists in
Locomotor activity detects subunit- analgesia 349 Alzheimer disease 15]
selective effects of agonists and Reggiani A Varty GB Schoenfeld D— Goff DC
decahydroisoquinoline antagonists at Reid L— Egerton A Schoepp DD— Johnson MP
AMPA/kainic acid ionotropic glutamate Remington G— Chung C Schoepp DD— Linden A-M
receptors in adult rats 181 Repeto P— Idris NF Scholey A, Kennedy D, Wesnes K: The
O’Shea E-— Saadat KS Rezvani AH, Caldwell DP, Levin ED: psychopharmacology of herbal extracts:
Ogden E- Silber BY Nicotinic-serotonergic drug issues and challenges 705
Oliveira AM-— Steckler T interactions and attentional performance Scholey AB— Haskell CF
Oliverio A— Ferretti V in rats 521 Schroeder JP, Overstreet DH, Hodge CW:
Olivier B— de Jong TR Ricchena M—> Neri S The mGluR5 antagonist MPEP
Ornstein PL— O'Neill MF Richards GJ— Spinelli S decreases operant ethanol self-
Osborne DJ > O'Neill MF Rickard JF Zhang Z administration during maintenance and
Overstreet DH — Schroeder JP Rinaldi A— Ferretti V : after repeated alcohol deprivations in
Ripoll N— Nick Dhonnchadha BA alcohol-preferring (P) rats 262
Palsson E— Klamer D Rizzo M, Lamers CTJ, Sauer CG, Schreiber S— Dolberg OT
Pace-Schott EF, Stickgold R, Muzur A, Ramaekers JG, Bechara A, Andersen Schuld A— Himmerich H
See RE— Fuchs RA antagonist EMD 281014 improves Wesnes KA — Haskell CF
Seers HE— Rogers PJ delayed matching performance in young Wichmann J— Spinelli S
Segal PN — Solinas M and aged rhesus monkeys 725 Wiedemann K —> Kellner M
Segato EN— Rebougas ECC Thorndike EB— Panlilio LV Wigren PE— Pace-Schott EF
Seibyl JP— Cho H-S Thornton-Jones ZD, Vickers SP, Clifton Will MJ— Der-Avakian A
Shaham Y-> Lé AD PG: The cannabinoid CBI receptor Williamson EM— Elsabagh S
Shannon H— Linden A-M antagonist SR141716A reduces Wilson SJ, Bailey JE, Nutt DJ: Dizziness
Sharp T— Denk F appetitive and consummatory responses produced by a potent SHT,, receptor
Shi J—Grippo AJ for food 452 agonist (eptapirone) is not due to
Shih V—> Goff DC Thorpe L— Gagiano C postural hypotension 895
Silber BY, Papafotiou K, Croft RJ, Ogden Tizzano JP— Johnson MP Wisniecki A— Betz A
E, Swann P, Stough C: The effects of Togashi H— Matsumoto M Wolf OT— Walpurger V
dexamphetamine on simulated driving Tsai G— Goff DC Woltering T— Spinelli S
performance 536 Tsami A— Neri S Woodhouse SM— O'Neill MF
Smith C— Purohit A Tsang SW— Lai MK Woolley ML— Ballard TM
Smith RL— Benneyworth MA Tunstall N— Rubia K
Solinas M, Goldberg SR: Involvement of Turle-Lorenzo N, Breysse N, Baunez C, Yamaguchi T— Matsumoto M
mu-, delta- and kappa-opioid receptor Amalric M: Functional interaction Yap JJ, Covington III HE, Gale MC,
subtypes in the discriminative-stimulus between mGlu 5 and NMDA receptors Datta R, Miczek KA: Behavioral
effects of delta-9-tetrahydrocannabinol in a rat model of Parkinson’s sensitization due to social defeat
(THC) in rats 804 disease 117 stress in mice: antagonism at mGluR5
Solinas M, Ferré S, Antoniou K, Quarta D, and NMDA receptors 230
Justinova Z, Hockemeyer J, Pappas LA, Van Craenendonck H-— Steckler T Yasar S— Goldberg SR
Segal PN, Wertheim C, Miiller CE, Van de Kar LD—Grippo AJ Yassouridis A— Himmerich H
Goldberg SR: Involvement of VanDoren MJ— Grobin AC Yassouridis A— Kellner M
adenosine A, receptors in the Varty GB, Grilli M, Forlani A, Fredduzzi S, Yee BK, Feldon J: Prepulse lost and
discriminative-stimulus effects of Grzelak ME, Guthrie DH, Hodgson RA, regained: a commentary on
caffeine in rats 576 Lu SX, Nicolussi E, Pond AJ, Parker "Weak prepulses inhibit but
Solomon P: Response to "The EM, Hunter JC, Higgins GA, Reggiani do not elicit startle in rats and
psychopharmacology of herbal extracts: A, Bertorelli R: The antinociceptive humans" Biological Psychiatry
issues and challenges" 710 and anxiolytic-like effects of the 55:98-101 891
Spencer RL— Der-Avakian A metabotropic glutamate receptor Yip JTH, Lee TMC: Effect of ecstasy use
Spinelli S, Ballard T, Gatti-McArthur S, 5 (mGluRS5) antagonists, MPEP on neuropsychological function: a study
Richards GJ, Kapps M, Woltering T, and MTEP, and the mGluR]! in Hong Kong 620
Wichmann J, Stadler H, Feldon J, Pryce antagonist, LY456236, in rodents: Yoshioka M— Matsumoto M
CR: Effects of the mGluR2/3 agonist a comparison of efficacy and Young D> Jaskiw GE
LY354740 on computerized tasks of side-effect profiles 207 Yovel I Goff DC
attention and working memory in Varvel SA, Anum EA, Lichtman AH: Yu JL— Linden A-M
marmoset monkeys 292 Disruption of CB, receptor signaling
Spooren W — Ballard TM impairs extinction of spatial memory in Zakharova ES, Danysz W, Bespalov AY:
Stadler H— Spinelli S mice 863 Drug discrimination analysis of NMDA
Stark K— Kellner M Veening JG— de Jong TR receptor channel blockers as nicotinic
Steckler T, Lavreysen H, Oliveira AM, Vickers SP— Thornton-Jones ZD receptor antagonists in rats 128
Aerts N, Van Craenendonck H, Vlachou S, Nomikos GG, Panagis G: CB, Zangrossi Jr H— dos Santos L
Prickaerts J, Megens A, Lesage ASJ: cannabinoid receptor agonists increase Zaudig M— Mergl R
Effects of mGlul receptor blockade on intracranial self-stimulation thresholds Zhang H— Goff DC
anxiety-related behaviour in the rat lick in the rat 498 Zhang H-T, Huang Y, Suvarna NU, Deng C,
suppression test 198 Crissman AM, Hopper AT, De Vivo M,
Steketee JD, Walsh TJ: Repeated injections Waldinger MD— Jong TR Rose GM, O’Donnell JM: Effects of the
of sulpiride into the medial prefrontal Walpurger V, Pietrowsky R, Djahansouzi S, novel PDE4 inhibitors MEM1018 and
cortex induces sensitization to cocaine in Wolf OT: No changes in event-related MEM1091 on memory in the radial-arm
rats 753 potentials with estrogen or estrogen plus maze and inhibitory avoidance tests in
Stephens DN— Mead AN progesterone treatment in healthy older rats 613
Stickgold R— Pace-Schott EF hysterectomized women: results from a Zhang J—> Klamer D
Stough C-—> Silber BY double-blind, placebo-controlled Zhang Y, Butelman ER, Schlussman SD,
Sullivan NR-—Grippo AJ study 652 Ho A, Kreek MJ: Effects of the plant-
Suvarna NU— Zhang H-T Walsh TJ— Steketee JD derived hallucinogen salvinorin A on
Svensson L— Klamer D Walton ME-— Denk F basal dopamine levels in the caudate
Swann P— Silber BY Ward AS-—P ace-Schott EF putamen and in a conditioned place
Swerdlow NR: Much ado about (almost) Watanabe A— Hasegawa S aversion assay in mice: agonist actions
nothing: response to ‘prepulse lost and Watkins LR — Der-Avakian A at kappa opioid receptors 551
regained’ 893 Weerts EM, Goodwin AK, Griffiths RR, Zhang Z, Rickard JF, Asgari K, Body S,
Szabadi E— Zhang Z Brown PR, Froest! W, Jakobs C, Gibson Bradshaw CM, Szabadi E: Quantitative
Szeliga P— Page ME KM: Spontaneous and precipitated analysis of the effects of some "atypical"
withdrawal after chronic intragastric and "conventional" antipsychotics on
Tachibana K—> Matsumoto M administration of gamma- progressive ratio schedule
Tahara K— Matsumoto M hydroxybutyrate (GHB) in performance 489
Taylor JR—> Chambers RA baboons 678
Teitler M— Purohit A Weiner I— Lipina T Indexed in/abstracted by Current Contents,
Terry Jr AV, Buccafusco JJ, Bartoszyk GD: Wertheim C— Solinas M Psychological Abstracts, Psyc INFO,
Selective serotonin 5-HT>, receptor Wesnes K— Scholey A Index Medicus and in EMBASE